|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
XENE | EMPFIELD JAMES R. | EVP, Drug Discovery | Aug 12 | Option Exercise | 4.24 | 65,000 | 275,750 | 75,000 | Aug 16 05:36 PM |
XENE | EMPFIELD JAMES R. | EVP, Drug Discovery | Aug 12 | Sale | 38.31 | 57,743 | 2,211,978 | 10,000 | Aug 16 05:36 PM |
XENE | EMPFIELD JAMES R. | EVP, Drug Discovery | Mar 04 | Option Exercise | 8.40 | 25,000 | 210,000 | 35,000 | Mar 08 07:32 PM |
XENE | EMPFIELD JAMES R. | EVP, Drug Discovery | Mar 07 | Option Exercise | 6.86 | 42,500 | 291,400 | 51,805 | Mar 08 07:32 PM |
XENE | EMPFIELD JAMES R. | EVP, Drug Discovery | Mar 07 | Sale | 30.54 | 32,853 | 1,003,475 | 10,000 | Mar 08 07:32 PM |
XENE | EMPFIELD JAMES R. | EVP, Drug Discovery | Mar 04 | Sale | 30.79 | 18,315 | 563,919 | 10,000 | Mar 08 07:32 PM |
XENE | EMPFIELD JAMES R. | SVP, Drug Discovery | Aug 15 | Buy | 2.48 | 10,000 | 24,824 | 10,000 | Aug 17 05:33 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite